Antiviral Drugs Market to Clock US$82.9 bn by 2024, Rise in Number of FDA approval to Fuel Market’s Growth
A new research report by Transparency Market Research on the global antiviral drugs market provide all the necessary insights and information required for formulation precise marketing strategies. According to the research report, the global market for antiviral drugs will exhibit a healthy CAGR of 6.40% over the course of the given forecast period of 2016 to 2024. The market is projected to reach a valuation worth US$82.9 bn by the end of the forecast period in 2024.
A new research report by Transparency Market Research on the global antiviral drugs market provide all the necessary insights and information required for formulation precise marketing strategies. According to the research report, the global market for antiviral drugs will exhibit a healthy CAGR of 6.40% over the course of the given forecast period of 2016 to 2024. The market is projected to reach a valuation worth US$82.9 bn by the end of the forecast period in 2024.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Antiviral drugs refer to those prescription medicines that are capable of fighting against
flu viruses in one’s body.
Antiviral drugs could include intravenous solutions, an inhaled powder, liquid, or pills.
The global antiviral drugs market is likely to observe considerable growth due to the
rising incidences of viral infections.
As coronavirus spreads at an exponential rate and the number of deaths crosses 74,000
worldwide, efforts are being made to lessen transmission through standard public health
interventions. These interventions are based on tracing of contacts and isolation of cases.
So far, there is no drug or vaccine to contain the spread of the pandemic worldwide.
©2019 Transparency Market Research, All Rights Reserved
Change language